Friday, April 23rd
7:00 a.m. - Continental Breakfast
Clinical Issues in Heart Failure
Dr. David Murray, presiding
7:50 a.m. - Introduction
8:00 a.m. - Gene Expression in Dilated Cardiomyopathy -
Diagnostic and Pharmacological Implications
Dr. Dell' Italia
8:25 a.m. - The Natriuretic Peptide Family in Cardiac
Failure - Diagnostic and Pharmacological Implications
Dr. de Lemos
8:50 a.m. - New Pharmacologic Options in Systolic Dysfunction
Dr. Murray
9:15 a.m. - Panel Discussion
Drs. Dell Italia, de Lemos and Murray
9:45 a.m. - Coffee Break
10:05 a.m. - Introduction
10:15 a.m. - Primary Prevention of Sudden Cardiac
Death in LV Systolic Dysfunction - CAD (MADIT I) vs. IDC
Dr. Greenspon
10:40 a.m. - Antithrombotic Therapy in Heart Failure
Dr. Ezekowitz
11:05 a.m. - Stem Cells and Myoblasts to Treat LV Dysfunction -
State-of-the-Science
Dr. Bailey
11:30 a.m. - Panel Discussion
Drs. Greenspon, Ezekowitz, Bailey and Chilton
12:00 p.m. - Lunch
Advances in Therapy for Arrhythmias
Dr. Alexis Fenton, presiding
1:20 p.m. - Introduction
1:30 p.m. - Post M. I. Guidelines:
Overview of the
Clinical Problem of Atrial Fibrillation/Flutter
Dr. Ezekowitz
1:55 p.m. - Optimizing Medical Therapy for
Atrial Fibrillation
Dr. Gregeratos
2:20 p.m. - Radiofrequency Ablation and Other Nonpharmacologic Therapies of
Supraventricular Tachycardia
Dr. Wilber
2:45 p.m. - Panel Discussion
Drs. Ezekowitz, Gregeratos, Wilber and Fenton
3:00 p.m. - Coffee Break
3:30 - 5:00 p.m. - WorkShop: Syncope Evaluation and
Case Studies: How to Evaluate a Syncope Patient
Dr. Greenspon
Unusual Causes of Syncope
Dr. Wilber
Case Presentations
Drs. Greenspon and Wilber
Saturday, April 26
7:00 a.m. - Continental Breakfast
Valvular Heart Disease
Dr. Gregory Freeman, presiding
7:50 a.m. - Introduction
8:00 a.m. - Surgery for Mitral Valve Disease and
Atrial Fibrillation.
Mitral Valve Repair or Replacement and the MAZE Procedure
Dr. Edward Sako
8:25 a.m. - Echocardiographic assessment of Valvular Heart Disease
New Imaging Modalities
Dr. Zabalgoitia
8:50 a.m. - Applying the Guidelines for Valvular Heart Disease
Dr. O'Gara
9:15 a.m. - Panel Discussion
Drs. Sako, Zabalgoitia, O'Gara and Freeman
9:45 a.m. - Coffee Break
Congenital Heart Disease: Who
Should We Be Treating?
Dr. Steven Bailey, presiding
10:05 a.m. - Neurologic Perspective on Embolization in the Setting of PFO-ASD
Dr. Wechsler
10:25 a.m. - Echocardiographic Diagnosis and Intraop Echo of ASD
Dr. Perez
10:50 a.m. - When to Treat a PFO ... and How
Dr. Kramer
11:15 a.m. - Atrial Exclusion ... the newest therapy for Atrial Fibrillation
Dr. Riesman
11:45 a.m. - Panel Discussion -
Drs. Wechsler, Perez, Kramer, Reisman and Bailey
12:00 p.m. - Adjournment and Program Evaluation
(Return to previous schedule)
